Category Archives: pharmacy

Did your doctor, nurse or pharmacist get paid to give talks for Merck?

If you lived in the US, you’d know.
The Wall Street Journal reports that Merck has just released its list of payments to doctors for giving talks at promotional events. The list also includes some nurses, pharmacists and scientists.
The payments range from $150 to more than $20,000.
The paper reports that many drug companies are moving to [...]

Menadue writes pharmacy sector a script for change

The conversations must have been lively at the Pharmacy Australia Congress in Sydney over the weekend. Health reform advocate John Menadue really socked it to the audience, judging by his 3,500-word speech.
For the sake of time-pressed Croakey readers, I’ve compressed the speech into several dot points. But it is worth reading in full, and you [...]

Why aren’t we making better use of pharmacy?

Why isn’t Australia making better use of its pharmacy resources?
That’s the question on health consultant Simon Burrow’s mind as he jetsets across the world. He’s picked up a few ideas from South Africa and the United States that he suggests might be useful/relevant for health reform in Oz.
He writes:
“The recent primary healthcare debate and [...]

TGA faces some questions over Sigma cruise

Sue Dunlevy did this story about Sigma, a generic drug manufacturer, wanting to take GPs and pharmacists on a luxury cruise visiting Italy, Malta, Corsica and Monte Carlo.  Former Victorian premier Jeff Kennett is billed as the keynote speaker at the conference advertised in the Australian Doctor magazine. The story was also picked up here.
Dr [...]

A who’s who of lobbyists in health

There’s an interesting analysis at Crikey today about the implications of Dr Andrew Pesce’s election as AMA president.
I wish I’d read it before giving a talk to health policy students at the ANU yesterday about lobby groups in health. Of course, you always end up preparing for these things at the last moment, generally late [...]

Some more thoughts on the Baker/Sanofi deal

A pharmacy researcher who wishes to remain anonymous has sent in this comment regarding the funding deal between the Baker and Sanofi Aventis (for more background info, see here, and here and here):
“Agreements between not for profit research institutes and the pharmaceutical industry can be fraught with conflict, even if an iron clad contract is [...]

Some critical issues for clinical practice guidelines

Agnes Vitry, Senior Research Fellow, School of Pharmacy and Medical Sciences, University of South Australia, has sent in this detailed, thoughtful response to the recent Croakey survey on the issues surrounding the controversial, commercially-funded Australian and NZ guidelines for blood clot prevention (for more background, see previous Croakey posts).
Vitry’s comments are well worth a read:
1. [...]

Have you heard the one about pharmacists, a wall, and a bag of money?

Simon Burrow has sent in this comment on the recent Crikey article by CHOICE’S Michael Johnston calling for the community’s interests to be factored into forthcoming Government-Guild negotiations:
“It’s a well known fact that if you want to break a wall down quickly, place
a pharmacist on one side and a bag of money on another. Demolition [...]